Clinical Trial Transparency training for Mundipharma Italia

Maxer Consulting put in place a training course dedicated to Clinical Trial Transparency for Mundipharma Italia.

The two sessions, attended by the professionals from the medical and the clinical research departments, focused on the legal framework and the governing principles the basis of the clinical trial transparency, and the procedures of anonymisation and redaction that EMA indicates for the submission of the dossier and the synopsis from the Clinical Study Report.

Maxer’s consultants devoted ample space to the drafting of the layperson summaries, with insights on the writing techniques and the measurement of the readability indices.

The training program addressed the most relevant issues related to Clinical Trial Transparency. Maxer’s consultants devoted ample space to the drafting of the layperson summaries, with insights on the writing techniques and the measurement of the readability indices.

The training program addressed the most relevant issues related to Clinical Trial Transparency. The course activities allowed the participants to acquire the know-how needed to guarantee the access and the understanding of the clinical trials for both the healthcare professionals and the layperson.